RNA
HealthcareAvidity Biosciences, Inc.
$13.83-0.71 (-4.88%)
Prev Close
$14.54
Open
$14.47
High
$14.55
Low
$13.82
Volume
467.6K
Market Cap
$2.30B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Avidity Biosciences, Inc. (RNA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 64 insider sales totaling $53.39M. The most recent insider transaction was by Boyce Sarah (director, officer: President and CEO), who sold $1.04M worth of shares on Jan 23, 2026. Avidity Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.30B.
Buys (12M)
0
$0.00
Sells (12M)
64
$53.39M
Net Activity
Net Seller
$53.39M
Active Insiders
11
last 12 mo
RNA Price Chart
RNA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Boyce Sarah | director, officer: President and CEO | Sell | 14,387 | $72.45 | $1.04M | 277,000 |
| Jan 23, 2026↗ | Flanagan W. Michael | officer: Chief Scientific Officer | Sell | 6,534 | $72.45 | $473.4K | 87,651 |
| Jan 23, 2026↗ | Hughes Steven George | officer: Chief Medical Officer | Sell | 4,895 | $72.45 | $354.6K | 34,477 |
| Jan 23, 2026↗ | LEVIN ARTHUR A | director | Sell | 1,758 | $72.45 | $127.4K | 16,562 |
| Jan 23, 2026↗ | MacLean Michael F | officer: Chief Financial Officer | Sell | 4,542 | $72.45 | $329.1K | 62,025 |
| Jan 23, 2026↗ | McCarthy Teresa | officer: Chief Human Resources Officer | Sell | 2,929 | $72.45 | $212.2K | 115,391 |
| Jan 21, 2026↗ | Boyce Sarah | President and CEO | Sell | 14,387 | $72.45 | $1.04M | 0 |
| Jan 21, 2026↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 6,534 | $72.45 | $473.4K | 0 |
| Jan 21, 2026↗ | Hughes Steven George | Chief Medical Officer | Sell | 4,895 | $72.45 | $354.6K | 0 |
| Jan 21, 2026↗ | LEVIN ARTHUR A | Director | Sell | 1,758 | $72.45 | $127.4K | 0 |
| Jan 21, 2026↗ | MacLean Michael F | Chief Financial Officer | Sell | 4,542 | $72.45 | $329.1K | 0 |
| Jan 21, 2026↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 2,929 | $72.45 | $212.2K | 0 |
| Jan 9, 2026↗ | Boyce Sarah | director, officer: President and CEO | Sell | 8,576 | $72.23 | $619.4K | 283,394 |
| Jan 9, 2026↗ | Calderaro Charles III | officer: Chief Technical Officer | Sell | 3,727 | $72.23 | $269.2K | 49,797 |
| Jan 9, 2026↗ | Flanagan W. Michael | officer: Chief Scientific Officer | Sell | 2,373 | $72.23 | $171.4K | 91,627 |
| Jan 9, 2026↗ | Hughes Steven George | officer: Chief Medical Officer | Sell | 2,373 | $72.23 | $171.4K | 36,494 |
| Jan 9, 2026↗ | MacLean Michael F | officer: Chief Financial Officer | Sell | 1,974 | $72.23 | $142.6K | 63,832 |
| Jan 9, 2026↗ | McCarthy Teresa | officer: Chief Human Resources Officer | Sell | 1,965 | $72.23 | $141.9K | 116,867 |
| Jan 9, 2026↗ | Moriarty John B | officer: Chief Legal Officer | Sell | 2,374 | $72.23 | $171.5K | 74,557 |
| Jan 7, 2026↗ | Boyce Sarah | President and CEO | Sell | 8,576 | $72.23 | $619.4K | 0 |
| Jan 7, 2026↗ | Calderaro Charles III | Chief Technical Officer | Sell | 3,727 | $72.23 | $269.2K | 0 |
| Jan 7, 2026↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 2,373 | $72.23 | $171.4K | 0 |
| Jan 7, 2026↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,373 | $72.23 | $171.4K | 0 |
| Jan 7, 2026↗ | MacLean Michael F | Chief Financial Officer | Sell | 1,974 | $72.23 | $142.6K | 0 |
| Jan 7, 2026↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 1,965 | $72.23 | $141.9K | 0 |
| Jan 7, 2026↗ | Moriarty John B | Chief Legal Officer | Sell | 2,374 | $72.23 | $171.5K | 0 |
| Dec 17, 2025↗ | Boyce Sarah | President and CEO | Sell | 15,742 | $71.87 | $1.13M | 0 |
| Dec 17, 2025↗ | Calderaro Charles III | Chief Technical Officer | Sell | 9,726 | $71.87 | $699.0K | 0 |
| Dec 17, 2025↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 13,695 | $71.87 | $984.3K | 0 |
| Dec 17, 2025↗ | Gallagher Kathleen P. | Chief Program Officer | Sell | 41,366 | $71.87 | $2.97M | 0 |
| Dec 17, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 17,298 | $71.87 | $1.24M | 0 |
| Dec 17, 2025↗ | Moriarty John B | Chief Legal Officer | Sell | 26,824 | $71.87 | $1.93M | 0 |
| Dec 17, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 47,990 | $71.87 | $3.45M | 0 |
| Oct 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,209 | $47.54 | $105.0K | 0 |
| Oct 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 20,000 | $50.15 | $1.00M | 0 |
| Oct 3, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 6,562 | $45.38 | $297.8K | 0 |
| Sep 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $40.58 | $89.6K | 0 |
| Sep 15, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $45.41 | $70.0K | 0 |
| Sep 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 15,000 | $41.41 | $621.1K | 0 |
| Sep 11, 2025↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 20,000 | $38.94 | $778.7K | 0 |
| Sep 5, 2025↗ | Boyce Sarah | President and CEO | Sell | 50,000 | $49.95 | $2.50M | 0 |
| Sep 5, 2025↗ | WILSON TROY EDWARD | Director | Sell | 29,500 | $50.00 | $1.48M | 0 |
| Sep 3, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 6,563 | $47.07 | $308.9K | 0 |
| Sep 2, 2025↗ | Gallagher Kathleen P. | Chief Program Officer | Sell | 188 | $47.42 | $8.9K | 0 |
| Aug 28, 2025↗ | Boyce Sarah | President and CEO | Sell | 25,000 | $49.39 | $1.23M | 0 |
| Aug 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $46.40 | $102.5K | 0 |
| Aug 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 10,000 | $46.56 | $465.6K | 0 |
| Aug 13, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $46.66 | $71.9K | 0 |
| Aug 6, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 81,434 | $42.74 | $3.48M | 0 |
| Aug 6, 2025↗ | LEVIN ARTHUR A | Director | Sell | 107,500 | $47.62 | $5.12M | 0 |
Showing 1–50 of 66
1 / 2
RNA Insider Buying Activity
The following table shows recent insider purchases of Avidity Biosciences, Inc. (RNA) stock reported via SEC Form 4 filings.
No insider buying activity found for RNA in the last 12 months.
RNA Insider Selling Activity
The following table shows recent insider sales of Avidity Biosciences, Inc. (RNA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Boyce Sarah | director, officer: President and CEO | Sell | 14,387 | $72.45 | $1.04M | 277,000 |
| Jan 23, 2026↗ | Flanagan W. Michael | officer: Chief Scientific Officer | Sell | 6,534 | $72.45 | $473.4K | 87,651 |
| Jan 23, 2026↗ | Hughes Steven George | officer: Chief Medical Officer | Sell | 4,895 | $72.45 | $354.6K | 34,477 |
| Jan 23, 2026↗ | LEVIN ARTHUR A | director | Sell | 1,758 | $72.45 | $127.4K | 16,562 |
| Jan 23, 2026↗ | MacLean Michael F | officer: Chief Financial Officer | Sell | 4,542 | $72.45 | $329.1K | 62,025 |
| Jan 23, 2026↗ | McCarthy Teresa | officer: Chief Human Resources Officer | Sell | 2,929 | $72.45 | $212.2K | 115,391 |
| Jan 21, 2026↗ | Boyce Sarah | President and CEO | Sell | 14,387 | $72.45 | $1.04M | 0 |
| Jan 21, 2026↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 6,534 | $72.45 | $473.4K | 0 |
| Jan 21, 2026↗ | Hughes Steven George | Chief Medical Officer | Sell | 4,895 | $72.45 | $354.6K | 0 |
| Jan 21, 2026↗ | LEVIN ARTHUR A | Director | Sell | 1,758 | $72.45 | $127.4K | 0 |
| Jan 21, 2026↗ | MacLean Michael F | Chief Financial Officer | Sell | 4,542 | $72.45 | $329.1K | 0 |
| Jan 21, 2026↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 2,929 | $72.45 | $212.2K | 0 |
| Jan 9, 2026↗ | Boyce Sarah | director, officer: President and CEO | Sell | 8,576 | $72.23 | $619.4K | 283,394 |
| Jan 9, 2026↗ | Calderaro Charles III | officer: Chief Technical Officer | Sell | 3,727 | $72.23 | $269.2K | 49,797 |
| Jan 9, 2026↗ | Flanagan W. Michael | officer: Chief Scientific Officer | Sell | 2,373 | $72.23 | $171.4K | 91,627 |
| Jan 9, 2026↗ | Hughes Steven George | officer: Chief Medical Officer | Sell | 2,373 | $72.23 | $171.4K | 36,494 |
| Jan 9, 2026↗ | MacLean Michael F | officer: Chief Financial Officer | Sell | 1,974 | $72.23 | $142.6K | 63,832 |
| Jan 9, 2026↗ | McCarthy Teresa | officer: Chief Human Resources Officer | Sell | 1,965 | $72.23 | $141.9K | 116,867 |
| Jan 9, 2026↗ | Moriarty John B | officer: Chief Legal Officer | Sell | 2,374 | $72.23 | $171.5K | 74,557 |
| Jan 7, 2026↗ | Boyce Sarah | President and CEO | Sell | 8,576 | $72.23 | $619.4K | 0 |
| Jan 7, 2026↗ | Calderaro Charles III | Chief Technical Officer | Sell | 3,727 | $72.23 | $269.2K | 0 |
| Jan 7, 2026↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 2,373 | $72.23 | $171.4K | 0 |
| Jan 7, 2026↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,373 | $72.23 | $171.4K | 0 |
| Jan 7, 2026↗ | MacLean Michael F | Chief Financial Officer | Sell | 1,974 | $72.23 | $142.6K | 0 |
| Jan 7, 2026↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 1,965 | $72.23 | $141.9K | 0 |
| Jan 7, 2026↗ | Moriarty John B | Chief Legal Officer | Sell | 2,374 | $72.23 | $171.5K | 0 |
| Dec 17, 2025↗ | Boyce Sarah | President and CEO | Sell | 15,742 | $71.87 | $1.13M | 0 |
| Dec 17, 2025↗ | Calderaro Charles III | Chief Technical Officer | Sell | 9,726 | $71.87 | $699.0K | 0 |
| Dec 17, 2025↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 13,695 | $71.87 | $984.3K | 0 |
| Dec 17, 2025↗ | Gallagher Kathleen P. | Chief Program Officer | Sell | 41,366 | $71.87 | $2.97M | 0 |
| Dec 17, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 17,298 | $71.87 | $1.24M | 0 |
| Dec 17, 2025↗ | Moriarty John B | Chief Legal Officer | Sell | 26,824 | $71.87 | $1.93M | 0 |
| Dec 17, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 47,990 | $71.87 | $3.45M | 0 |
| Oct 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,209 | $47.54 | $105.0K | 0 |
| Oct 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 20,000 | $50.15 | $1.00M | 0 |
| Oct 3, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 6,562 | $45.38 | $297.8K | 0 |
| Sep 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $40.58 | $89.6K | 0 |
| Sep 15, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $45.41 | $70.0K | 0 |
| Sep 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 15,000 | $41.41 | $621.1K | 0 |
| Sep 11, 2025↗ | Flanagan W. Michael | Chief Scientific Officer | Sell | 20,000 | $38.94 | $778.7K | 0 |
| Sep 5, 2025↗ | Boyce Sarah | President and CEO | Sell | 50,000 | $49.95 | $2.50M | 0 |
| Sep 5, 2025↗ | WILSON TROY EDWARD | Director | Sell | 29,500 | $50.00 | $1.48M | 0 |
| Sep 3, 2025↗ | Mosbrooker Eric | Chief Commercial Officer | Sell | 6,563 | $47.07 | $308.9K | 0 |
| Sep 2, 2025↗ | Gallagher Kathleen P. | Chief Program Officer | Sell | 188 | $47.42 | $8.9K | 0 |
| Aug 28, 2025↗ | Boyce Sarah | President and CEO | Sell | 25,000 | $49.39 | $1.23M | 0 |
| Aug 22, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $46.40 | $102.5K | 0 |
| Aug 15, 2025↗ | McCarthy Teresa | Chief Human Resources Officer | Sell | 10,000 | $46.56 | $465.6K | 0 |
| Aug 13, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $46.66 | $71.9K | 0 |
| Aug 6, 2025↗ | Hughes Steven George | Chief Medical Officer | Sell | 81,434 | $42.74 | $3.48M | 0 |
| Aug 6, 2025↗ | LEVIN ARTHUR A | Director | Sell | 107,500 | $47.62 | $5.12M | 0 |
RNA Insiders
Similar Stocks to RNA
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B